Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05801198
PHASE2

Addressing Asymptomatic Plasmodium Reservoirs to Accelerate Malaria Elimination and Eradication in Rwanda.

Sponsor: King Faisal Hospital Rwanda

View on ClinicalTrials.gov

Summary

The investigators believe that to effectively achieve malaria elimination in Rwanda, it is critical to target the human reservoirs of Plasmodium falciparum using local and readily available Artemisia tea. Asymptomatic infections detectable by PCR are important reservoirs because they often persist for months and harbor gametocytes, the parasite stage infectious to mosquitoes. Lessons learnt from this study will be of critical importance for health decision makers with regard to potential malaria control. MSc and PhD students will be trained and the impact of this research project will be enormous on the socioeconomic transformation of Rwanda.

Official title: Addressing Both Naturally Occurring and ACT-induced Plasmodium Reservoirs Using Artemisia Infusions to Accelerate Malaria Elimination and Eradication in Rwanda: A Proof of Concept Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

125

Start Date

2024-03-01

Completion Date

2026-12-31

Last Updated

2023-10-17

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

Artemisia afra or Annua 10g oral infusion/tea per day for 14 days

Participants will be recruited after completing standard malaria treatment, and those who have a positive qRT-PCR for plasmodium gametocyte reservoirs will be randomly assigned to either artemisia afra tea, or artemisia annua tea or into the control group with no intervention